Eprobemide is a reversible monoamine oxidase A inhibitor and is classified as a drug for depression.

Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.

Moxonidine is a selective agonist of imidazoline I1 receptors and alpha-2 receptor used as an antihypertensive drug.

Moxonidine HCl is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.

Efaroxan hydrochloride is an antagonist of α2 adrenoceptor and imidazoline I1 receptor ligand. The pKi values are 7.87, 7.42, 5.74, 7.28 and < 5 for α2A, α2B, α2C, I1 and I2 receptors, respectively.